GoodRx Holdings, Inc. (GDRX)
3.42
+0.03
(+0.88%)
USD |
NASDAQ |
Sep 14, 09:40
GoodRx Holdings Price to Book Value : 1.796 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.780 |
| September 10, 2026 | 1.760 |
| September 09, 2026 | 1.754 |
| September 08, 2026 | 1.849 |
| September 04, 2026 | 1.828 |
| September 03, 2026 | 1.854 |
| September 02, 2026 | 1.812 |
| September 01, 2026 | 1.817 |
| August 31, 2026 | 1.833 |
| August 28, 2026 | 1.854 |
| August 27, 2026 | 1.844 |
| August 26, 2026 | 1.917 |
| August 25, 2026 | 1.825 |
| August 24, 2026 | 1.807 |
| August 21, 2026 | 1.812 |
| August 20, 2026 | 1.870 |
| August 19, 2026 | 1.859 |
| August 18, 2026 | 1.917 |
| August 17, 2026 | 1.954 |
| August 14, 2026 | 1.959 |
| August 13, 2026 | 1.954 |
| August 12, 2026 | 1.886 |
| August 11, 2026 | 1.996 |
| August 10, 2026 | 1.922 |
| August 07, 2026 | 1.933 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.954 |
| August 05, 2026 | 1.717 |
| August 04, 2026 | 1.754 |
| August 03, 2026 | 1.660 |
| July 31, 2026 | 1.612 |
| July 30, 2026 | 1.665 |
| July 29, 2026 | 1.691 |
| July 28, 2026 | 1.639 |
| July 27, 2026 | 1.602 |
| July 24, 2026 | 1.555 |
| July 23, 2026 | 1.507 |
| July 22, 2026 | 1.539 |
| July 21, 2026 | 1.586 |
| July 20, 2026 | 1.649 |
| July 17, 2026 | 1.649 |
| July 16, 2026 | 1.639 |
| July 15, 2026 | 1.607 |
| July 14, 2026 | 1.581 |
| July 13, 2026 | 1.597 |
| July 10, 2026 | 1.549 |
| July 09, 2026 | 1.544 |
| July 08, 2026 | 1.555 |
| July 07, 2026 | 1.591 |
| July 06, 2026 | 1.618 |
| July 02, 2026 | 1.602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LataMed AI Corp. | 9.736 |
| SCWorx Corp. | 0.0386 |
| Health Catalyst, Inc. | 1.287 |
| Claritev Corp. | -- |
| iSpecimen, Inc. | 1.271 |
Price to Book Value Related Metrics
| PE Ratio | 72.77 |
| PS Ratio | 1.500 |
| Price to Free Cash Flow | 8.946 |
| Price | 3.42 |
| Earnings Yield | 1.37% |
| Market Cap | 1.163B |
| Operating PE Ratio | 12.50 |
| Normalized PE Ratio | 39.68 |